1,809 followers
Moreover, responses have been seen with mTOR inhibitors, gemcitabine/docetaxel, and denosumab. https://t.co/Ex0zNyAqQO https://t.co/So410Fh5Tk
Moreover, responses have been seen with mTOR inhibitors, gemcitabine/docetaxel, and denosumab. https://t.co/Ex0zNyAqQO https://t.co/So410Fh5Tk
Pseudomyogenic hemangioendothelioma of bone treated with denosumab: a case report #ASBMR #BoneScienceNews https://t.co/TiAda1lFTe